MedTrace Logo

Efficacy of Dengue Infection With Warning Signs Treated With Dexamethasone (DengDex Study)

NCT05631405 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-08-07

No results posted yet for this study

Summary

The goal of this randomized double-blinded placebo-controlled trial is to learn about dexamethasone and the treatment of severe dengue population. The main question it aims to answer are steroid therapy may be effective in dengue.

Conditions

  • Severe Dengue

Interventions

DRUG

Dexamethasone

Patients treated with dexamethasone

DRUG

Placebo

Patients treated with placebo

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-16
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05631405 on ClinicalTrials.gov